发明名称 Method of selecting stem cells having high chondrogenic differentiation capability
摘要 Thrombospondin 1 (TSP-1), TSP-2, interleukin 17B receptor (IL-17BR) and heparin-binding epidermal growth factor-like growth factor (HB-EGF) associated with stem cell activity and use thereof.
申请公布号 US9040298(B2) 申请公布日期 2015.05.26
申请号 US201012790268 申请日期 2010.05.28
申请人 Medipost Co., Ltd. 发明人 Yang Yoon-Sun;Oh Won Il;Jeon Hong Bae;Jung Mee Hyun;Jeong Sang Young
分类号 C12N5/00;A61K38/17;A61K38/18;A61K38/39 主分类号 C12N5/00
代理机构 Drinker Biddle & Reath LLP 代理人 Drinker Biddle & Reath LLP
主权项 1. A method of selecting a stem cell capable of differentiating into a chondrocyte or inducing chondrocyte differentiation, the method comprising: culturing a stem cell in a monolayer or pellet in a maintenance medium; measuring a concentration of TSP-2; and selecting and isolating a stem cell having a high chondrogenic differentiation capability from the culture medium if a) the concentration of TSP-2 in cell culture is larger than 72 pg/ml/1.0×105 cells when the stem cell is monolayer cultured for 1 day, or b) the concentration of TSP-2 in cell culture is larger than 550 pg/ml/1.0×105 cells when the stem cell is pellet cultured for 7 days, wherein the selected stem cell is capable of differentiating into a chondrocyte or inducing chondrocyte differentiation.
地址 Seoul KR